Table Of Contents

1. Market Context & Strategic Relevance
 1.1 Opening Context (Why the market matters)
  1.1.1 Why This Market Is Gaining Strategic Attention
  1.1.2 Business Decisions This Report Supports
 1.2 Scope
 1.3 Research & Methodology

2. Executive Summary
 2.1 Market Snapshot
 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
 2.3 Market Size & Forecast, By Segmentation, 2022–2035
  2.3.1 Market Size By Production Method
  2.3.2 Market Size By Purity Grade
  2.3.3 Market Size By Application
  2.3.4 Market Size By Indication
  2.3.5 Market Size By End User
 2.4 Market Share & Bps Analysis By Region, 2025
 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
 2.6 Industry CxO's Perspective

3. Market Overview
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Key Market Trends
 3.2 Industry PESTLE Analysis
 3.3 Key Industry Forces (Porter's) Impacting Market Growth
 3.4 Industry Supply Chain Analysis
  3.4.1. Raw Material & Isotope Suppliers
  3.4.2. Actinium-225 Producers & Manufacturers
  3.4.3. Radiopharmaceutical Developers
  3.4.4. End Users (Hospitals, Research Institutes, Pharma Companies)
 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting
 4.1 Production & Supply Metrics
  4.1.1 Global Annual Production Capacity of Actinium-225 (Millicuries/Year)
  4.1.2 Average Isotope Yield Per Production Cycle (Millicuries)
  4.1.3 Production Yield Efficiency by Method (% of Theoretical Maximum)
  4.1.4 Average Production Lead Time by Method (Days)
  4.1.5 Percentage of Global Supply from Government vs. Commercial Producers (%)
 4.2 Purity & Quality Metrics
  4.2.1 Average Radiochemical Purity of Commercial Actinium-225 Supply (%)
  4.2.2 Percentage of Supply Meeting Clinical-Grade Specifications (%)
  4.2.3 Average Radionuclidic Purity Levels of Non-Carrier-Added Supply (%)
  4.2.4 Impurity Profile Benchmarking (Actinium-227 Contamination Levels in ppm)
  4.2.5 Percentage of Batches Requiring Re-purification Before Use (%)
 4.3 Clinical & Therapeutic Metrics
  4.3.1 Average Dose Per Patient in Targeted Alpha Therapy (Microcuries)
  4.3.2 Number of Active Clinical Trials Utilizing Actinium-225 (Count)
  4.3.3 Average Treatment Cycle Duration in Actinium-225 Based Therapies (Weeks)
  4.3.4 Percentage of Targeted Alpha Therapy Procedures Using Ac-225 vs. Other Alpha Emitters (%)
  4.3.5 Average Cost Per Dose of Actinium-225 Based Radiopharmaceuticals (USD)
 4.4 Supply Chain & Logistics Indicators
  4.4.1 Average Distribution Time from Production Site to End User (Hours)
  4.4.2 Percentage of Global Supply Impacted by Isotope Decay During Transit (%)
  4.4.3 Average Shelf Life Utilization Rate of Actinium-225 Shipments (%)
  4.4.4 Percentage of Facilities with On-Site Cyclotron or Accelerator Capability (%)
  4.4.5 Average Global Supply-Demand Gap (Millicuries/Year)

5. Actinium-225 Supply Market Segmental Analysis & Forecast, By Production Method, 2022–2035, Value (USD Billion)
 5.1 Introduction
 5.2 Thorium-229 Decay
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022–2035
 5.3 Cyclotron-Based (Accelerator) Production
 5.4 Linear Accelerator Production
 5.5 Reactor-Based (Radium-226 Irradiation) Production

6. Actinium-225 Supply Market Segmental Analysis & Forecast, By Purity Grade, 2022–2035, Value (USD Billion)
 6.1 Introduction
 6.2 Carrier-Added
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022–2035
 6.3 Non-Carrier-Added

7. Actinium-225 Supply Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
 7.1 Introduction
 7.2 Targeted Alpha Therapy
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022–2035
 7.3 Radioimmunotherapy
 7.4 Diagnostic & Research Use

8. Actinium-225 Supply Market Segmental Analysis & Forecast, By Indication, 2022–2035, Value (USD Billion)
 8.1 Introduction
 8.2 Prostate Cancer
  8.2.1 Key Trends
  8.2.2 Market Size & Forecast, 2022–2035
 8.3 Neuroendocrine Tumors
 8.4 Acute Myeloid Leukemia & Hematologic Malignancies
 8.5 Others

9. Actinium-225 Supply Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
 9.1 Introduction
 9.2 Pharmaceutical & Biopharmaceutical Companies
  9.2.1 Key Trends
  9.2.2 Market Size & Forecast, 2022–2035
 9.3 Research Institutes & National Laboratories
 9.4 Hospitals & Cancer Centers
 9.5 Contract Manufacturing Organizations (CDMOs)

10. Actinium-225 Supply Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
 10.1 Introduction
 10.2 North America
  10.2.1 Key Trends
  10.2.2 Actinium-225 Supply Market Size & Forecast, By Production Method, 2022–2035
  10.2.3 Actinium-225 Supply Market Size & Forecast, By Purity Grade, 2022–2035
  10.2.4 Actinium-225 Supply Market Size & Forecast, By Application, 2022–2035
  10.2.5 Actinium-225 Supply Market Size & Forecast, By Indication, 2022–2035
  10.2.6 Actinium-225 Supply Market Size & Forecast, By End User, 2022–2035
  10.2.7 Actinium-225 Supply Market Size & Forecast, By Country, 2022–2035
   10.2.7.1 USA
   10.2.7.2 Canada
 10.3 Europe
  10.3.1 Key Trends
  10.3.2 Actinium-225 Supply Market Size & Forecast, By Production Method, 2022–2035
  10.3.3 Actinium-225 Supply Market Size & Forecast, By Purity Grade, 2022–2035
  10.3.4 Actinium-225 Supply Market Size & Forecast, By Application, 2022–2035
  10.3.5 Actinium-225 Supply Market Size & Forecast, By Indication, 2022–2035
  10.3.6 Actinium-225 Supply Market Size & Forecast, By End User, 2022–2035
  10.3.7 Actinium-225 Supply Market Size & Forecast, By Country, 2022–2035
   10.3.7.1 Germany
   10.3.7.2 UK
   10.3.7.3 France
   10.3.7.4 Italy
   10.3.7.5 Spain
   10.3.7.6 Russia
   10.3.7.7 Poland
   10.3.7.8 Rest of Europe
 10.4 Asia-Pacific
  10.4.1 Key Trends
  10.4.2 Actinium-225 Supply Market Size & Forecast, By Production Method, 2022–2035
  10.4.3 Actinium-225 Supply Market Size & Forecast, By Purity Grade, 2022–2035
  10.4.4 Actinium-225 Supply Market Size & Forecast, By Application, 2022–2035
  10.4.5 Actinium-225 Supply Market Size & Forecast, By Indication, 2022–2035
  10.4.6 Actinium-225 Supply Market Size & Forecast, By End User, 2022–2035
  10.4.7 Actinium-225 Supply Market Size & Forecast, By Country, 2022–2035
   10.4.7.1 China
   10.4.7.2 India
   10.4.7.3 Japan
   10.4.7.4 South Korea
   10.4.7.5 Australia
   10.4.7.6 ASEAN Countries
   10.4.7.7 Rest of Asia-Pacific
 10.5 Latin America
  10.5.1 Key Trends
  10.5.2 Actinium-225 Supply Market Size & Forecast, By Production Method, 2022–2035
  10.5.3 Actinium-225 Supply Market Size & Forecast, By Purity Grade, 2022–2035
  10.5.4 Actinium-225 Supply Market Size & Forecast, By Application, 2022–2035
  10.5.5 Actinium-225 Supply Market Size & Forecast, By Indication, 2022–2035
  10.5.6 Actinium-225 Supply Market Size & Forecast, By End User, 2022–2035
  10.5.7 Actinium-225 Supply Market Size & Forecast, By Country, 2022–2035
   10.5.7.1 Brazil
   10.5.7.2 Argentina
   10.5.7.3 Mexico
   10.5.7.4 Colombia
   10.5.7.5 Rest of Latin America
 10.6 Middle East & Africa
  10.6.1 Key Trends
  10.6.2 Actinium-225 Supply Market Size & Forecast, By Production Method, 2022–2035
  10.6.3 Actinium-225 Supply Market Size & Forecast, By Purity Grade, 2022–2035
  10.6.4 Actinium-225 Supply Market Size & Forecast, By Application, 2022–2035
  10.6.5 Actinium-225 Supply Market Size & Forecast, By Indication, 2022–2035
  10.6.6 Actinium-225 Supply Market Size & Forecast, By End User, 2022–2035
  10.6.7 Actinium-225 Supply Market Size & Forecast, By Country, 2022–2035
   10.6.7.1 UAE
   10.6.7.2 Saudi Arabia
   10.6.7.3 Qatar
   10.6.7.4 South Africa
   10.6.7.5 Rest of Middle East & Africa

11. Competitive Landscape
 11.1 Key Players' Positioning
 11.2 Competitive Developments
  11.2.1 Year-Wise Strategies & Development, 2022–2026
 11.3 Market Share Analysis, 2025
 11.4 Product/Service & Application Benchmarking
  11.4.1 Product/Service Specifications & Features By Key Players
  11.4.2 Product/Service Heatmap By Key Players
  11.4.3 Application Heatmap By Key Players
 11.5 Industry Start-Up & Innovation Landscape
11.6 Key Company Profiles
  11.6.1 TerraPower Isotopes
   11.6.1.1 Company Overview & Snapshot
   11.6.1.2 Product/Service Portfolio
   11.6.1.3 Key Company Financials
   11.6.1.4 Geographical Presence
   11.6.1.5 SWOT Analysis
  11.6.2 NorthStar Medical Radioisotopes, LLC
  11.6.3 Oak Ridge National Laboratory (DOE Isotope Program)
  11.6.4 Los Alamos National Laboratory
  11.6.5 Brookhaven National Laboratory
  11.6.6 Eckert & Ziegler Radiopharma GmbH
  11.6.7 BWX Technologies, Inc. (BWXT Medical)
  11.6.8 ITM Isotope Technologies Munich SE
  11.6.9 Actineer Inc.
  11.6.10 Canadian Nuclear Laboratories
  11.6.11 Orano Med
  11.6.12 PanTera GmbH
  11.6.13 Ion Beam Applications SA (IBA)
  11.6.14 Niowave, Inc.
  11.6.15 TRIUMF
  11.6.16 Fusion Pharmaceuticals Inc. (AstraZeneca)
  11.6.17 Telix Pharmaceuticals Limited
  11.6.18 Bayer AG
  11.6.19 Novartis AG
  11.6.20 Cardinal Health, Inc.

12. Analyst Recommendations
 12.1 SNS Insider Opportunity Map
 12.2 Industry Low-Hanging Fruit Assessment
 12.3 Market Entry & Growth Strategy
 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix
 15.1 List Of Tables
 15.2 List Of Figures